Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH -0.81%44 EBIT per Share is ₹7.69 as of Mar. 2026. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 44/100. The stock has 3 warning signs investors should review. Among 524 Healthcare Providers & Services companies, GPT Healthcare ranks worse than 70.42% on this metric.
GPT Healthcare's EBIT per Share for the
three
months ended in Mar. 2026 was ₹2.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.69.
During the past 12 months, the average EBIT per Share Growth Rate of GPT Healthcare was -14.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -0.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 7.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for GPT Healthcare's EBIT per Share or its related term are showing as below:
NSE:GPTHEALTH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -0.8 Med: 4.1 Max: 24.1
Current: -0.8
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of GPT Healthcare was 24.10% per year. The lowest was -0.80% per year. And the median was 4.10% per year.
NSE:GPTHEALTH's 3-Year EBIT Growth Rate is ranked worse than 70.42% of 524
companies
in the Healthcare Providers & Services industry
Industry Median: 11.95
vs NSE:GPTHEALTH: -0.80
GPT Healthcare's EBIT for the
three
months ended in Mar. 2026 was ₹180 Mil.
GPT Healthcare (NSE:GPTHEALTH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
GPT Healthcare EBIT per Share Related Terms
GPT Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for GPT Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare (NSE:GPTHEALTH) has a EBIT per Share of ₹7.69 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on GPT Healthcare and its competitors. According to the industry distribution chart, GPT Healthcare ranks #369 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 70.4%.
Is GPT Healthcare's EBIT per Share too high?
GPT Healthcare's current EBIT per Share is ₹7.69. Based on the distribution chart, GPT Healthcare ranks #369 out of 524 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #369 out of 524 companies for EBIT per Share. This places GPT Healthcare in the lower half of its industry. The industry median EBIT per Share is 11.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.95, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current EBIT per Share is ₹7.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current EBIT per Share of ₹7.69. The current EBIT per Share is ₹7.69. GPT Healthcare's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current EBIT per Share is ₹7.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
44GF Score
Get the complete analysis for NSE:GPTHEALTH
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
